Trademark: 88397912
Word
DRUGOME
Status
Registered
Status Code
700
Status Date
Tuesday, June 23, 2020
Serial Number
88397912
Registration Number
6083085
Registration Date
Tuesday, June 23, 2020
Mark Type
4000
Filing Date
Tuesday, April 23, 2019
Published for Opposition
Tuesday, April 7, 2020

Trademark Owner History
SUMITOMO PHARMA CO. LTD. -
SUMITOVANT BIOPHARMA, INC. - Original Registrant
Roivant Sciences GmbH - Owner At Publication

Classifications
9 Downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; downloadable computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable computer software for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest
36 Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and clinical and post-market trials
35 Advertising; business management; business administration; office functions; business research services in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials, and post-market data; business information services; market research; provision of market research information; data processing services; analysis of business data; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes
42 Scientific and technological services, namely, scientific research and analysis in the field of pharmaceuticals and biomedicine; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing featuring software for conducing scientific research and analysis in the fields of public health, healthcare, pharmaceutical and biomedical research, clinical trial data and data from examinations carried out after the introduction of medicines on the market; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; Artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services
DRUG O ME

Trademark Events
Jan 24, 2024
Automatic Update Of Assignment Of Ownership
Sep 6, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 6, 2022
Teas Change Of Correspondence Received
Sep 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 6, 2022
Teas Change Of Owner Address Received
Jun 23, 2020
Registered-Principal Register
Apr 7, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 7, 2020
Published For Opposition
Mar 25, 2020
Assignment Of Ownership Not Updated Automatically
Mar 18, 2020
Notification Of Notice Of Publication E-Mailed
Mar 3, 2020
Approved For Pub - Principal Register
Feb 25, 2020
Examiner's Amendment Entered
Feb 25, 2020
Assigned To Lie
Feb 25, 2020
Notification Of Examiners Amendment E-Mailed
Feb 25, 2020
Examiners Amendment E-Mailed
Feb 25, 2020
Examiners Amendment -Written
Feb 10, 2020
Previous Allowance Count Withdrawn
Feb 4, 2020
Withdrawn From Pub - Og Review Query
Jan 21, 2020
Approved For Pub - Principal Register
Dec 11, 2019
Teas/Email Correspondence Entered
Dec 11, 2019
Correspondence Received In Law Office
Dec 11, 2019
Teas Response To Office Action Received
Jun 11, 2019
Notification Of Non-Final Action E-Mailed
Jun 11, 2019
Non-Final Action E-Mailed
Jun 11, 2019
Non-Final Action Written
Jun 3, 2019
Assigned To Examiner
May 8, 2019
New Application Office Supplied Data Entered
Apr 26, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24